JP2010525033A5 - - Google Patents

Download PDF

Info

Publication number
JP2010525033A5
JP2010525033A5 JP2010504743A JP2010504743A JP2010525033A5 JP 2010525033 A5 JP2010525033 A5 JP 2010525033A5 JP 2010504743 A JP2010504743 A JP 2010504743A JP 2010504743 A JP2010504743 A JP 2010504743A JP 2010525033 A5 JP2010525033 A5 JP 2010525033A5
Authority
JP
Japan
Prior art keywords
insulin
aqueous solution
less
hexamer
zinc ions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010504743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010525033A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/055341 external-priority patent/WO2008132229A2/en
Publication of JP2010525033A publication Critical patent/JP2010525033A/ja
Publication of JP2010525033A5 publication Critical patent/JP2010525033A5/ja
Withdrawn legal-status Critical Current

Links

JP2010504743A 2007-04-30 2008-04-30 高濃縮のインスリン溶液及び組成物 Withdrawn JP2010525033A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07107221 2007-04-30
EP07109906 2007-06-08
EP07117798 2007-10-03
PCT/EP2008/055341 WO2008132229A2 (en) 2007-04-30 2008-04-30 Highly concentrated insulin solutions and compositions

Publications (2)

Publication Number Publication Date
JP2010525033A JP2010525033A (ja) 2010-07-22
JP2010525033A5 true JP2010525033A5 (enExample) 2014-09-18

Family

ID=39495516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504743A Withdrawn JP2010525033A (ja) 2007-04-30 2008-04-30 高濃縮のインスリン溶液及び組成物

Country Status (4)

Country Link
US (1) US20100120660A1 (enExample)
EP (2) EP2514412A1 (enExample)
JP (1) JP2010525033A (enExample)
WO (1) WO2008132229A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2601839T3 (es) 2006-09-22 2017-02-16 Novo Nordisk A/S Análogos de insulina resistentes a proteasas
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP5762001B2 (ja) * 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー/エス プロテアーゼ安定化インスリンアナログ
EP2910571B1 (en) 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
ES2636741T3 (es) * 2009-07-31 2017-10-09 Sanofi-Aventis Deutschland Gmbh Composición de insulina de acción prolongada
US10842951B2 (en) 2010-01-12 2020-11-24 Aerami Therapeutics, Inc. Liquid insulin formulations and methods relating thereto
US9180261B2 (en) 2010-01-12 2015-11-10 Dance Biopharm Inc. Preservative free insulin formulations and systems and methods for aerosolizing
WO2011161427A2 (en) * 2010-06-25 2011-12-29 Aston University Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
EP2646046A4 (en) * 2010-11-30 2015-03-18 Joslin Diabetes Center Inc COMPOSITIONS AND METHODS FOR TREATING NERVOUS DISORDER IN CONNECTION WITH DIABETES
MX342675B (es) * 2011-03-10 2016-10-07 Xeris Pharmaceuticals Inc Formulaciones estables para inyeccion parenteral de farmacos de peptido.
KR102007057B1 (ko) 2011-10-31 2019-08-02 엑스에리스 파머수티클스, 인크. 당뇨병 치료를 위한 제형물
JP6199956B2 (ja) 2012-04-11 2017-09-20 ノヴォ ノルディスク アー/エス インスリン製剤
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US20140179597A1 (en) * 2012-11-16 2014-06-26 Steven Lehrer Method for the treatment and prevention of Alzheimer's disease and central nervous system dysfunction
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
EP3185932A1 (en) 2014-08-06 2017-07-05 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
HK1245116A1 (zh) 2015-02-25 2018-08-24 Dance Biopharm Inc. 液体胰岛素制剂及与其相关的方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
EP3442998A4 (en) 2016-04-12 2020-04-01 Cell And Molecular Tissue Engineering, LLC SYSTEMS, METHODS AND PRODUCTS FOR MINIMIZING TISSUE REACTIONS AND TISSUE DAMAGE AT AN INFUSION SITE
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations
PE20210857A1 (es) 2016-12-16 2021-05-18 Novo Nordisk As Composiciones farmaceuticas que contienen insulina
CN110709061B (zh) 2017-06-02 2023-09-08 Xeris药物公司 抗沉淀的小分子药物制剂
US11478534B1 (en) * 2021-07-13 2022-10-25 America Great Health Formulation and method of preparing zinc-charged insulin for oral administration
US20230025595A1 (en) * 2021-07-13 2023-01-26 America Great Health, a California Corporation Formulation and Method of Preparing Divalent Cation Charged Insulin for Oral Administration

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23446A (en) * 1986-10-20 1989-08-07 Novo Industri As Peptide preparations
EP0280534B1 (en) * 1987-02-25 1993-04-21 Novo Nordisk A/S Novel insulin derivatives
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
EP1028706B1 (en) * 1997-11-12 2003-07-09 Alza Corporation Buffered drug formulations for transdermal electrotransport delivery
CN1210058C (zh) * 1998-10-16 2005-07-13 诺沃挪第克公司 用于肺送递的稳定的浓缩胰岛素制剂
EP1131089B1 (en) * 1998-11-18 2004-02-18 Novo Nordisk A/S Stable aqueous insulin preparations without phenol and cresol
US6489292B1 (en) * 1998-11-18 2002-12-03 Novo Nordisk A/S Stable aqueous insulin preparations without phenol and cresol
JP3799924B2 (ja) 2000-01-11 2006-07-19 株式会社日立製作所 電力用遮断器および発電所電気回路装置
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
CA2626357A1 (en) * 2005-10-20 2007-04-26 Nastech Pharmaceutical Company Inc. Intranasal administration of rapid acting insulin
JP5496082B2 (ja) * 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物

Similar Documents

Publication Publication Date Title
JP2010525033A5 (enExample)
Denis et al. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.
RU2470016C2 (ru) Производное бипиразола
RU2470642C2 (ru) Аналоги птерина для лечения состояния, чувствительного к вн4
JP2013519632A5 (enExample)
US20230128449A1 (en) Silicate containing compositions and methods of treatment
JP2019515908A5 (enExample)
RU2016147575A (ru) Непрерывное введение l-допа, ингибиторов допа-декарбоксилазы, ингибиторов катехол-о-метилтрансферазы и предназначенные для этого композиции
JP2011502997A5 (enExample)
JP2010525033A (ja) 高濃縮のインスリン溶液及び組成物
RU2013119966A (ru) Композиция, улучшающая растворимость плохорастворимого лекарственного препарата
RU2004101229A (ru) Дейтерированные n-и альфа-замещенные аминоалкилэфиры дифенилакоксиуксуной кислоты, а также лекарственные средства, содержащие эти соединения
RU2005135428A (ru) Поглощение макромолекул
CA2337484A1 (en) Fatty acid-containing composition
RU2011130508A (ru) Рецептура для перорального трансмукозального применения гиполипидемических лекарственных средств
ES2553107T3 (es) Composición anti-inflamatoria basada en compuestos de estroncio
CN1061415A (zh) 含s(+)-苯基链烷酸和氨基糖类的配合物
US20150258202A1 (en) Anthocyanidin complex for the treatment of multiple myeloma
JP6448847B2 (ja) 腹膜治療液及び腹膜治療液容器
RU2011109921A (ru) Препараты канфосфамида и их получения
WO2007058498A1 (en) Compositions for peritoneal dialysis
JPS6393718A (ja) 注射剤
CN1813795A (zh) 一种药物组合物
JP5371278B2 (ja) 透析用剤およびその製造方法
RU2009127858A (ru) Фармацевтическая композиция, включающая алискирен и авосентан